Philips Verida AI Spectral CT Wins FDA 510(k) Clearance
AMSTERDAM, Netherlands, April 16, 2026 Royal Philips has announced a major advancement in medical imaging with the U.S. FDA...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
AMSTERDAM, Netherlands, April 16, 2026 Royal Philips has announced a major advancement in medical imaging with the U.S. FDA...
CHICAGO, April 15, 2026 AIRS Medical has announced that its SwiftMR® AI-powered MRI image enhancement solution has received FDA...
CHICAGO, ILLINOIS, March 23, 2026 GE HealthCare has announced that the U.S. Food and Drug Administration (FDA) has granted...
mlHealth 360 has received U.S. FDA 510(k) clearance for Scaida BrainCT-ICH, the first Canada-developed AI-powered triage solution designed to...
